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Abstract The aimofthis studywas to investigatewhether systemic tumornecrosis factor alpha (TNF-a), solubleTNF-
a receptors (p55, p75), interleukin 6 (IL-6), and soluble IL-6 receptor could be markers of biological activities of coal
workers’pneumoconiosis (CWP).The studypopulationwascomposedof182Chineseretiredcoalminerswhohad similar
dustexposure histories.Among them,71were caseswith CWPand111were controls.Chest radiographswere classified
according to International Labour Organization Criteria (ILO,1980). Individual dust exposure variables were estimated
from work histories, and smoking information was obtained from interviews. Serum concentrations of TNF-a,TNF-a
receptors (p55, p75),IL-6, and IL-6 receptorweremeasuredby ELISAtechniques.Meanserumlevelsofp55, p75 and IL-6
were significantly higher in cases than in controls (Pr0.01 for each comparison by crude analyses).Results from logistic
regression models, adjusted for age, dust exposure variables, and smoking habits, found similar associations between
soluble p55 and p75 levels and the presence of CWP.Linear regression analysis revealed that CWP radiographic stage
(by ILO criteria) was significantly correlated with the individual serum concentrations of p55, p75 and IL-6. Serum con-
centrationsof allmeasuredcytokineswerenotcorrelatedto age, dustexposure, or smoking, buttherewere correlations
betweensolublep75 andp55 levels, andbetweenp75 and IL-6 levels.Theresultsofthis studysuggestthat serumlevelsof
TNF receptors and IL-6 are associated with the fibrotic process of CWP and serum cytokine levels may be correlated
withthe severityof CWP.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1367, available online athttp://www.idealibrary.comon
Keywords coal workers’ pneumoconiosis (CWP); tumor necrosis factor alpha (TNF-a); interleukin 6 (IL-6); soluble receptors.INTRODUCTION
Coal workers’ pneumoconiosis (CWP), characterized by
the development of a progressive ¢brotic reaction in the
lung, is still a major occupational lung disease in China as
well as in the other parts of theworld. Although thepre-
cise mechanism by which coal mine dust induces lung ¢-
brosis remains incompletely understood, accumulating
data suggest that dust-induced overproduction of speci-
¢c cytokines, such as tumor necrosis factor-alpha (TNF-
a) and interleukin 6 (IL-6)) are involved in the pathogen-
esis of lung ¢brosis (1^3).Received 5 December 2001, accepted in revised form12 April 2002.
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E-mail:rzhai@hotmail.comIn animal studies, silica/bleomycin inducesTNF-a pro-
duction and eventually, lung ¢brosis (3). This ¢brosis is
less intense with the concurrent administration of anti-
TNF antibody (3). Alveolar macrophages and blood
monocytes from patients with CWP release higher
amounts of TNF-a and IL-6 (4^6).The increased expres-
sion of TNF-a and IL-6mRNA in alveolarmacrophages is
also found in othermodels of occupational lung diseases,
including chronic berylliumdisease (7) and asbestosis (8).
There is greater secretion of TNF-a and IL-6 in the lungs
of patients with progressive massive ¢brosis (PMF) than
in simple pneumoconiosis (5). In addition, enhanced pro-
duction of TNF-a and IL-6 is found in areas of pulmonary
tissuewherecoaldustandsilicaparticlesarepresent(3,5).
Likemostpolypeptide cytokines,TNF-a and IL-6med-
iate their various cellular responsesbybinding to speci¢c
receptors (9).Mice lackingTNF receptor genes are resis-
tant to the ¢brogenic e¡ects of silica and bleomycin, de-
spite increasedproduction of TNF in the lung of themice
830 RESPIRATORYMEDICINE(10). In addition to the membrane-bound receptors, two
solubleTNF receptors, p55 (sTNF-RI), p75 (sTNF-RII), and
one soluble IL-6 receptor (sIL-6R) have been identi¢ed
(9). Systemic infusion of recombinant soluble p55 can re-
duce collagen deposition in the lung in animal models of
silica/bleomycin-induced lung ¢brosis, presumably by
downregulating the activities of TNF-a thatmediate pul-
monary ¢brosis (10). Elevated TNF-a receptors in
bronchoalveolar lavage have been observed in several in-
£ammatory lung diseases, including pulmonary ¢brosis,
suggesting that these receptors may be induced in re-
sponse to in£ammation (11).One study found that plasma
p55 and p75 levels are increased in a small group of pa-
tients with CWP compared to controls (12). Another
found elevated serum IL-6 and sIL-6R levels in patients
with systemic sclerosis (13).
Although these data suggest the importance of TNF
and IL-6 in the pathogenesis of CWP, little is known
about the in vivo relationship between serum levels of
TNF-a/TNF-a receptors and IL-6/IL-6 receptor in CWP.
In the present study, we compared the circulating levels
of TNF-a/receptors and IL-6/IL-6 receptor in coalminers
with andwithout CWP. In addition, we examined the re-
lationship between serum levels of cytokines and CWP
radiographic stage, a marker of disease severity.
MATERIALSANDMETHODS
Subjects
For this case-control study, participants consisted of182
retired coalminers (age 67.878.0 years, all males of Han
Chinese descent ) from the Heshan Coal Mine Company
in Guangxi Province,China. All subjects had spent their
entire working career with the same mining company.
Therefore, their dust exposure histories were known
and comparable quantitatively and qualitatively. The
miners from this company had been followed by com-
pany physicians from the time of employment through-
out their retirement, and had periodic screening chest
radiographs. Cases were identi¢ed from physician lists,
and retired miners known not to have CWP were cho-
sen as controls. Subjectswith a known record of current
or chronic diseases of lung, liver, and kidney, were ex-
cluded.TheHuman Subjects Committee ofHeshanGen-
eral Hospital approved this study.
Data Collection
Cases and controls were recruited by their physicians
and written informed consent was obtained from each
participant. All subjects received a routine medical ex-
amination that included a Chinese translation of the
standardized American Thoracic Society respiratory
questionnaire on respiratory symptoms, occupational
histories, and smoking habits (14). A chest radiographand a blood samplewere obtained. Smoking was quanti-
¢ed in packyears. Occupational dust exposure was de-
¢ned by two variables: the duration of exposure
(measured by the number of years working under-
ground) and cumulative dust exposure (in mgyears/m3).
Cumulative dust exposurewas calculatedby the formulaP
Eiti, where Ei is the intensity (mg/m
3) and ti the dura-
tion (years) of the ith interval of exposure (15).Eiwas de-
¢ned by the air dust concentrations measured annually
(prior to 1957) and monthly (since 1957) for the under-
ground mining area that the individual was assigned to
work. Radiographic staging of disease was performed
using chest radiographs, whichwere interpreted accord-
ing to ILO criteria (1980) (16) by a panel of three pulmon-
ary radiologists. Based on the ILO score, miners were
categorized into ¢ve ordinal stages re£ecting disease se-
verity.These radiographic stageswere scored as Grade 0
(ILO score of 0/0),Grade1 (ILO scores 0/1),Grade 2 (ILO
scores:1/0,1/1, and1/2) Grade 3 (ILO scores: 2/1, 2/2 and
2/3), and Grade 4 (ILO score of 3/1or higher). All miners
who were Grades 1^4 were classi¢ed as cases, because
even a score of 0/1 (Grade 1) has been correlated to
pathologic ¢brotic lesions in pneumoconiosis (17).
Detection of cytokines and cytokine
receptors
Serumwas separated from blood samples, and stored at
401C to prevent cytokine degradation. Commercially
available ELISA kits (Genzyme Corp., Cambridge, MA,
U.S.A.) were used to determine the serum concentra-
tions of TNF-a, sTNF-Rs, IL-6, and sIL-6R using the pro-
cedures provided by themanufacturers.The plates were
read at 450nm in an automated reader (Bio-Tek EL 311
instrument, Winooski, VT, U.S.A.). A standard curve
was generated using known concentrations of the re-
combinant form of the human cytokine/cytokine recep-
tor of interest.Values for sampleswere determinedusing
the linear portion of the curves for standards run in par-
allel with each batch of assays.
Statistical analysis
Continuous datawere expressed asmeans and standard
deviations. Mean serum levels of TNF-a, TNF-a recep-
tors, IL-6 and sIL-6R were compared between CWP
cases vs controls crudely, using the Student’s t-test (for
normally distributed) or the Mann^Whitney U-test (for
non-parametric data). A multiple logistic regression
model was constructed to compare cases vs controls,
adjusted for age, cumulative dust exposure, duration of
exposure, age of ¢rst dust exposure, smoking status, cu-
mulative active smoking, and the serum levels of other
cytokines/cytokine receptors.
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ate the association between serum levels of di¡erent cy-
tokines (or their receptors) and CWP radiographic
stage.Crude analyses, and analyses adjusted for the same
covariates as the logistic regression models were evalu-
ated. Radiographic stages were treated as ordinals. Be-
cause the number of individuals with Grades 3 and 4
disease were small, the two grades were merged into
one grade (known as 3/4) for all statistical analyses. Step-
wise linear regression was also used to evaluate associa-
tions among the cytokine/cytokine receptor levels. All
tests of signi¢cance were two tailed. Statistical analysis
wasperformedusing the SPSS forWindows 8.0 software
(SPSS, Inc.,Chicago).
RESULTS
Study population
A demographic summary of the study population is pre-
sented in Table 1. In this study population, 71/182 (39%)
were classi¢ed as CWP patients and111 (61%) were clas-
si¢ed as controls. Of the cases, 67 (93%) smoked regu-TABLE 1. Demographics of the studypopulation
Charactersitics CasesN=71
Age (years) 71.177.0
Smoking (packyears) 280.87187.2
Yearsworkingunderground 21.879.2
Age at ¢rstexposure 24.273.8
Cumulative dustexposurec 4287.572352.4
Timeretired (years) 15.875.5
aStudent’s t-test.
bMann^Whitney U-test.
amg years/m3.
TABLE 2. Mean serumlevels of cytokines
Cases
N=71
Controls
N=111
TNF-a (pg/ml) 1.771.7 1.471.1
p55 (pg/ml) 9157286 7047256
p75 (pg/ml) 10477240 8607211
IL-6 (pg/ml) 12.6712.3 7.278.3
sIL-6R (pg/ml) 10547544 10647508
aStudent’s t-test.
bMann^Whitney U-test.
Percent froma logistic regressionmodelwith serumlevel of each
exposure, duration of exposure, age of ¢rstexposure, smokinglarly at some point in their lives, while only 57 (52%) of
controls were ever smokers. However, no di¡erences
were observed between cases and controls in mean cu-
mulative smoking, measured as packyears. The reason
for this discrepancybetweenpackyears and smoking sta-
tus is easily explained: individuals diagnosed with CWP
were more likely to quit smoking than controls (either
from respiratory symptoms or from a greater motiva-
tion to quit). There were no di¡erences between cases
and controls in terms of duration of dust exposure or cu-
mulative dust exposure, whereas the mean age and the
average time of retirement in cases were signi¢cantly
higher than in cases (Table 1).Within CWP cases, 16, 43,
9 and 3 subjects were classi¢ed as Grades 1, 2, 3, and 4,
respectively.
Case^control analysis of serum
concentrations
Table 2 presents the mean serum concentrations of the
cytokines/cytokine receptors by case status. Serum va-
lues of p55 andp75, detected in all individuals, were each
signi¢cantly higher in cases vs controls in crude analysesControlsN=111 P value
66.276.2 o0.01a
276.07148.7 0.89b
20.1710.0 0.23a
25.475.5 0.08a
4098.672043.0 0.57a
11.676.1 o0.01a
P-value univariate P-valuemultivariate %
0.13a 0.25
o0.01a 0.01
o0.01a 0.01
o0.01b 0.40
0.92c 0.69
cytokine/cytokinereceptor, adjusted for age, cumulative dust
status, and cumulative active smoking.
FIG. 2. Mean serum p55 levels in controls (n=111), grade 1
CWPcases (n=16), grade 2 CWP subjects (n=43), and grade 3/4
CWPpatients (n=12).
FIG. 3. Meanserump75 levelsincontrols (n=111), grade1CWP
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justed logistic regression models (Pr0.01 for all compar-
isons). Serum IL-6 was detected in 66/71 (93%) cases and
in 93/111 (84%) controls (P=0.05). The mean serum IL-6
level was signi¢cantly higher than controls in crude ana-
lyses (Po0.01), but not in adjusted analyses (P=0.40).
There were no statistically signi¢cant di¡erences in
either serumTNF-a or sIL-6R levels between cases and
controls (P40.10 for all comparisons), or between the
proportions of cases vs. controls with measurable levels
of TNF-a (P=0.24).
Association between cytokine levels and
radiographic stages
No associations were found between serum levels of
TNF-a or IL-6R and radiographic stage. However, with
more severe radiographic stages (i.e. higher Grade), the
mean serum levels of p55, p75 or IL-6 were higher in
crude analyses (see Figs.1^3). In an adjustedlinear regres-
sion model, a higher radiographic stage was also signi¢-
cantly associated with a higher mean concentration of
soluble p55 (Po0.01), soluble 75 (Po0.01), and IL-6
(P=0.01) in the entire studypopulation.Considering cases
only, only serum levels of IL-6 were associated signi¢-
cantly with radiographic stage (Po0.01), although similar
non-signi¢cant trends were also seen between radio-
graphic stage and either soluble p55 or p75 levels.
Correlations among cytokine levels and
other continuous variables
We also evaluated potential correlations between di¡er-
ent cytokine/cytokine receptor levels. Serum p75 levels
were correlated to serum p55 levels (Fig. 4; correlation
coe⁄cient R2=0.09; Po0.01 by linear regression), while
serum p75 levels were correlated to serum IL-6 levelsFIG. 1. Meanserum IL-6 levelsincontrols (n=111), grade1CWP
cases (n=16), grade 2 CWPsubjects (n=43), andgrade, 3/4 CWP
patients (n=12).(Fig. 5; R2=0.18; Po0.01 by linear regression). Higher cu-
mulative smoking exposure (packyears as a continuous
variable) was associated with a higher CWP stagecases (n=16), grade 2 CWPsubjects (n=43), andgrade 3/4 CWP
patients (n=12).
FIG. 4. Soluble p55 vs. p75 levels.
FIG. 5. Serum IL-6 vs. soluble p75 levels.
SERUMCYTOKINES,COALWORKERS’PNEUMOCONIOSIS 833(P=0.05). No cytokine/cytokine receptor levels were as-
sociatedwith age, smoking, or dust exposure levels.
To account for di¡erences in smoking status between
cases and controls, we incorporated smoking status
(using indicator variables) andpackyears (as a continuous
variable) in all adjustedmodels, and performed separate
subanalyses limited to ever smokers. In every subanalysis,
logistic and linear regression results were similar to ana-
lyses involving the entire population.
DISCUSSION
Airway in£ammation is a characteristic of CWP, and
TNF-a is an in£ammatory cytokine (1,2). SolubleTNF re-
ceptors may represent an attempt by homeostatic me-
chanisms to ameliorate the systemic e¡ects of TNF-a
(18). Soluble TNF receptors are derived by proteolytic
cleavage from the extracellular portions of their respec-
tive membrane-associated TNF receptors (9).These so-
lubleTNF receptors can neutralize circulatingTNF-a (18),
thus modulating excessive circulatingTNF-a and amelio-
rate in£ammatory reactions (19). In the present study,
mean serum levels of theTNF-a soluble receptors, p55
andp75, but not TNF-a itself, were higher in coalminers
with CWP compared to controls.High levels of TNF re-
ceptors may account for the lack of increased TNF-a in
the systemic circulation of cases (19).This increase in so-
lubleTNF receptors was a relatively early event in CWP
patients, as TNF-a levels were already increased in
miners with Grade1disease. An alternative explanation
for why we did no detect a mean serum level di¡erence
inTNF-a in cases vs controls is that TNF-a production
was suppressed by the higher levels of IL-6 in our cases
(20, 26).
In the in£ammatory milieu of the lung, the interac-
tions of TNF-a and its inhibitors (such asTNF soluble re-
ceptors) are complex. Although the p55 and p75
receptors are structurally related, each TNF receptor
may be functionally distinct (23). For example, it was re-
ported that most biological responses of TNF-a are
mediated through p55, while p75 functions as both aTNF-a antagonist (by neutralizingTNF-a) and as aTNF-a
agonist by facilitating the interaction between TNF-a
and p55 at the cell surface (21). In vitro studies found that
p55 mediates cytotoxicity, whereas p75 stimulates cell
proliferation (22). In double receptor knockout mice,
the upregulated expression of p75, but not p55, was re-
sistant to the ¢brotic e¡ects of silica (32).
Mean serum IL-6 level, but not mean soluble IL-6 re-
ceptor level, was higher in cases than in controls.Higher
mRNA production or concentrations of IL-6 were re-
ported in either the pulmonary tissue or BAL £uid of
pneumoconiotic patients vs controls (5,24,25). When
compared to healthy controls, higher BAL £uid levels of
IL-6 were observed in patients with either systemic
sclerosis with pulmonary ¢brosis (13) or idiopathic pul-
monary ¢brosis (24). Our results, together with these
previous ¢ndings, suggest that systemic IL-6 may play a
role in the pathogenesis of pulmonary ¢brosis in CWP.
Although a few studies have evaluatedbothTNF-a and
IL-6 levels in CWP development (24^25), or p55 p75 in
the plasma of CWP patients (12), none have examined
the association between serum levels of these cyto-
kines/cytokine receptors and CWP radiographic stages.
We report thatmean p55 and p75, and IL-6 serum levels
progressively increasedwith increasing severity of CWP.
Multiple linear regression models con¢rmed that these
were independent linear trends in both crude and ad-
justedmodels.
Cumulative smoking was associatedwith CWP sever-
ity with borderline statistical signi¢cance (P=0.05). Data
from histologic studies and animal experiment suggest,
that occasionally smoking can cause di¡usepulmonary ¢-
brosis with low profusion ratings (27). However,
whether cigarette smoking cancauseradiographic opaci-
ties indistinguishable from those due to pneumoconiosis
remains controversial. In some studies, the presence of
chest radiographic opacities was found to correlate sig-
ni¢cantly with cigarette smoking (28), while others dis-
puted this association (29). It is also possible that
cigarette smokemay increase lung in£ammation, enhan-
cing the ¢brogenic e¡ects of in£ammatory mediators
(such asTNF-a) that are produced from coal dust expo-
sure.
Unlike other soluble cytokine receptors, sIL-6R has
no antagonistic role, but enhances the response to IL-6
(30). We found no di¡erence between miners with
CWP and without CWP in serum sIL-6R levels.
Although IL-6 downregulates sIL-6R gene expression
both in vivo and in vitro (31), we found no such correlation
in our sample of CWP patients.
In conclusion, our study found that higher levels of so-
luble TNF receptors and higher IL-6 serum levels were
each associated independently with the presence of
CWP, and with the radiographic severity of CWP.
Although we performedmultiple comparisons between
di¡erent serologic in£ammatory markers, the consis-
834 RESPIRATORYMEDICINEtency of the results across strati¢ed and adjusted ana-
lyses, consistency across previous reports in this ¢eld (al-
beit most had signi¢cantly smaller sample sizes),
independence of association in multivariate models, and
biologic plausibility lend legitimacy to our results.These
¢ndings are consistent with the role of cytokines in the
in£ammatory pathway, where factors are known to sti-
mulate the production of each other (2). Although our
results do not identify the biological basis for these ¢nd-
ings, these results underscore the potential complex in-
teractions between soluble TNF receptors and IL-6 in
the pathogenesis of coal-dust-induced CWP.
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